Incidences and trends of second cancers in female breast cancer patients: A fixed inception cohort-based analysis (United States)

Cancer Causes and Control

Volumn 17, Issue 4, 2006, Pages 411-420

  Yu, Guo Pei ^a,b   Schantz, Stimson P ^a,b,c   Neugut, Alfred I ^d   Zhang, Zuo Feng ^e  

^a NEW YORK EYE AND EAR INFIRMARY   (United States)

^b NEW YORK MEDICAL COLLEGE   (United States)

^c STRANG CANCER PREVENTION CENTER   (United States)

^d Columbia University ^*  (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Breast cancer; Incidence; Second cancers

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER DIAGNOSIS; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RISK; CLINICAL OBSERVATION; COHORT ANALYSIS; CONTROLLED STUDY; ENDOMETRIUM CANCER; FEMALE; HEALTH CARE ORGANIZATION; HEALTH PROGRAM; HUMAN; KIDNEY CANCER; LEUKEMIA; LUNG CANCER; MAJOR CLINICAL STUDY; MELANOMA; NONHODGKIN LYMPHOMA; POPULATION; PRIORITY JOURNAL; RISK ASSESSMENT; THYROID CANCER; TIME SERIES ANALYSIS; UNITED STATES; UTERUS CANCER;

ADULT; AGED; BREAST NEOPLASMS; COHORT STUDIES; FEMALE; HUMANS; INCIDENCE; MIDDLE AGED; NEOPLASMS, SECOND PRIMARY; ODDS RATIO; UNITED STATES;

EID: 33645505545     PISSN: 09575243     EISSN: 15737225     Source Type: Journal    
DOI: 10.1007/s10552-005-0338-y     Document Type: Article

References (46)

1. Sadetzki S, Calderon-Margalit R, Peretz C, Novikov I, Barchana M, Papa MZ (2003) Second primary breast and thyroid cancers (Israel). Cancer Causes Control 14:367-375
2. Zheng T, Holford TR, Chen Y, Ma JZ, Flannery J, Liu W, Russi M, Boyle P (1996) Time trend and age-period-cohort effect on incidence of thyroid cancer in Connecticut, 1935-1992. Int J Cancer 67:504-509
3. Colonna M, Grosclaude P, Remontet L, Schvartz C, Mace-Lesech J, Velten M, Guizard A, Tretarre B, Buemi AV, Arveux P, Esteve J (2002) Incidence of thyroid cancer in adults recorded by French cancer registries (1978-1997). Eur J Cancer 38:1762-1768
4. Liu S, Semenciw R, Ugnat AM, Mao Y (2001) Increasing thyroid cancer incidence in Canada, 1970-1996: time trends and age-period-cohort effects. Br J Cancer 85:1335-1339
5. Surveillance, Epidemiology, and End Results (SEER) Program (www.seer.cancer.gov) SEER*Stat Database: Incidence - SEER 9 Regs Public-Use, Nov 2003 Sub (1973-2001), National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, released April 2004: based on the November 2003 submission
6. Breslow NE, Day NE (1987) Statistical methods in cancer research, Vol. 2. The design and analysis of cohort studies. International Agency for Research on Cancer, Lyon
7. Schoenberg BS, Myers MH (1977) Statistical methods for studying multiple primary malignant neoplasms. Cancer 40:1892-1898
8. Nicodemus KK, Sweeney C, Folsom AR (2004) Evaluation of dietary, medical and lifestyle risk factors for incident kidney cancer in postmenopausal women. Int J Cancer 108:115-121
9. Hu J, Mao Y, White K (2003) Overweight and obesity in adults and risk of renal cell carcinoma in Canada. Soz Praventivmed 48:178-185
10. Tate R, Iddenden R, Harnden P, Morris E, Craigs C, Bennett C, Brook C, Haward RA, Forman D (2003) Increased incidence of renal parenchymal carcinoma in the Northern and Yorkshire region of England, 1978-1997. Eur J Cancer 39:961-967
11. Gross TP, Wise RP, Knapp DE (1989) Antihypertensive drug use. Trends in the United States from 1973 to 1985. Hypertension 13:I113-I118
12. Beral V, Peterman T, Berkelman R, Jaffe H (1991) AIDS-associated non-Hodgkin lymphoma. Lancet 337:805-809
13. Gail MH, Pluda JM, Rabkin CS, Biggar RJ, Goedert JJ, Horm JW, Sondik EJ, Yarchoan R, Broder S (1991) Projections of the incidence of non-Hodgkin's lymphoma related to acquired immunodeficiency syndrome. J Natl Cancer Inst 83:695-701
14. Kinlen LJ (2000) Non-Hodgkin's lymphoma after immunosuppressive therapy. Gut 47:462-463
15. Elwood JM, Jopson J (1997) Melanoma and sun exposure: an overview of published studies. Int J Cancer 73:198-203
16. Travis WD, Lubin J, Ries L, Devesa S (1996) United States lung carcinoma incidence trends: declining for most histologic types among males, increasing among females. Cancer 77:2464-2470
17. McPherson CP, Sellers TA, Potter JD, Bostick RM, Folsom AR (1996) Reproductive factors and risk of endometrial cancer. The Iowa Women's Health Study. Am J Epidemiol 143:1195-1202
18. Archer DF (2004) Neoplasia of the female reproductive tract: effects of hormone therapy. Endocrine 24:259-263
19. Dunn BK, Wickerham DL, Ford LG (2005) Prevention of hormone-related cancers: breast cancer. J Clin Oncol 23:357-367
20. Fournier A, Berrino F, Riboli E, Avenel V, Clavel-Chapelon F (2005) Breast cancer risk in relation to different types of hormone replacement therapy in the E3N-EPIC cohort. Int J Cancer 114:448-454
21. Stewart HJ (1992) The Scottish trial of adjuvant tamoxifen in node-negative breast cancer. Scottish Cancer Trials Breast Group. J Natl Cancer Inst Monogr 117-120
22. Peters-Engl C, Frank W, Danmayr E, Friedl HP, Leodolter S, Medl M (1999) Association between endometrial cancer and tamoxifen treatment of breast cancer. Breast Cancer Res Treat 54:255-260
23. Fornander T, Rutqvist LE, Cedermark B, Glas U, Mattsson A, Silfversward C, Skoog L, Somell A, Theve T, Wilking N, et al (1989) Adjuvant tamoxifen in early breast cancer: occurrence of new primary cancers. Lancet 1:117-120
24. Ursic Vrscaj M, Kovacic J, Bebar S, Djurisic A, Fras PA, Robic V (2001) Endometrial and other primary cancers after tamoxifen treatment of breast cancer - results of retrospective cohort study. Eur J Obstet Gynecol Reprod Biol 95:105-110
25. Sasco AJ, Chaplain G, Amoros E, Saez S (1996) Endometrial cancer following breast cancer: effect of tamoxifen and castration by radiotherapy. Epidemiology 7:9-13
26. Rutqvist LE, Johansson H, Signomklao T, Johansson U, Fornander T, Wilking N (1995) Adjuvant tamoxifen therapy for early stage breast cancer and second primary malignancies Stockholm Breast Cancer Study Group. J Natl Cancer Inst 87:645-651
27. Fisher B, Costantino JP, Redmond CK, Fisher ER, Wickerham DL, Cronin WM (1994) Endometrial cancer in tamoxifen-treated breast cancer patients: findings from the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-14. J Natl Cancer Inst 86:527-537
28. Matesich SM, Shapiro CL (2003) Second cancers after breast cancer treatment. Semin Oncol 30:740-748
29. Kyle RA (1982) Second malignancies associated with chemotherapeutic agents. Semin Oncol 9:131-142
30. Fisher B, Rockette H, Fisher ER, Wickerham DL, Redmond C, Brown A (1985) Leukemia in breast cancer patients following adjuvant chemotherapy or postoperative radiation: the NSABP experience. J Clin Oncol 3:1640-1658
31. Curtis RE, Boice JD, Jr., Stovall M, Bernstein L, Greenberg RS, Flannery JT, Schwartz AG, Weyer P, Moloney WC, Hoover RN (1992) Risk of leukemia after chemotherapy and radiation treatment for breast cancer. N Engl J Med 326:1745-1751
32. Hahn P, Nelson N, Baral E (1994) Leukemia in patients with breast cancer following adjuvant chemotherapy and/or postoperative radiation therapy. Acta Oncol 33:599-602
33. Chaplain G, Milan C, Sgro C, Carli PM, Bonithon-Kopp C (2000) Increased risk of acute leukemia after adjuvant chemotherapy for breast cancer: a population-based study. J Clin Oncol 18:2836-2842
34. Carli PM, Sgro C, Parchin-Geneste N, Isambert N, Mugneret F, Girodon F, Maynadie M (2000) Increase therapy-related leukemia secondary to breast cancer. Leukemia 14:1014-1017
35. Crump M, Tu D, Shepherd L, Levine M, Bramwell V, Pritchard K (2003) Risk of acute leukemia following epirubicin-based adjuvant chemotherapy: a report from the National Cancer Institute of Canada Clinical Trials Group. J Clin Oncol 21:3066-3071
36. Goggins W, Gao W, Tsao H (2004) Association between female breast cancer and cutaneous melanoma. Int J Cancer 111:792-794
37. Hemminki K, Vaittinen P (1997) Interaction of breast cancer and melanoma genotypes. Lancet 350:931-932
38. Borg A, Sandberg T, Nilsson K, Johannsson O, Klinker M, Masback A, Westerdahl J, Olsson H, Ingvar C (2000) High frequency of multiple melanomas and breast and pancreas carcinomas in CDKN2A mutation-positive melanoma families. J Natl Cancer Inst 92:1260-1266
39. Chen Y, Thompson W, Semenciw R, Mao Y (1999) Epidemiology of contralateral breast cancer. Cancer Epidemiol Biomarkers Prev 8:855-861
40. Bernstein JL, Thompson WD, Risch N, Holford TR (1992) Risk factors predicting the incidence of second primary breast cancer among women diagnosed with a first primary breast cancer. Am J Epidemiol 136:925-936
41. Gao X, Fisher SG, Emami B (2003) Risk of second primary cancer in the contralateral breast in women treated for early-stage breast cancer: a population-based study. Int J Radiat Oncol Biol Phys 56:1038-1045
42. de Koning HJ, van Dongen JA, van der Maas PJ (1994) Changes in use of breast-conserving therapy in years 1978-2000. Br J Cancer 70:1165-1170
43. Harris JR, Recht A, Connolly J, Cady B, Come S, Henderson IC, Koufman C, Love S, Schnitt S, Osteen R (1990) Conservative surgery and radiotherapy for early breast cancer. Cancer 66:1427-1438
44. Neugut AI, Weinberg MD, Ahsan H, Rescigno J (1999) Carcinogenic effects of radiotherapy for breast cancer. Oncology (Huntingt) 13:1245-1256. discussion 1257: 1261-1245
45. Roychoudhuri R, Evans H, Robinson D, Moller H (2004) Radiation-induced malignancies following radiotherapy for breast cancer. Br J Cancer 91:868-872
46. Harvey EB, Brinton LA (1985) Second cancer following cancer of the breast in Connecticut, 1935-82. Natl Cancer Inst Monogr 68:99-112